Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 5, 2010, Pages 942-949

  Lavigne Lissalde, G ^a   Sanchez, C ^a   Castelli, C ^b   Alonso, S ^b   Mazoyer, E ^c   Bal Dit Sollier, C ^d   Drouet, L ^d   Juhan Vague, I ^a   Gris, J C ^e   Alessi, M C ^a   Morange, P E ^a  

^a INSERM   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

^c AVICENNE HOSPITAL   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e Lab Biol Cell Cytogenetique M   (France)

Author keywords

PT G20210A; Thrombin generation; Venous thrombosis

Indexed keywords

PROTHROMBIN; THROMBIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL FEATURE; FEMALE; GENE MUTATION; HEREDITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VEIN THROMBOSIS; BIOSYNTHESIS; GENETICS; HETEROZYGOTE DETECTION; METABOLISM; MIDDLE AGED; MUTATION;

ADULT; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTHROMBIN; THROMBIN; VENOUS THROMBOSIS;

EID: 77953742952     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03773.x     Document Type: Article

References (29)

1. Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannuccio P, Mannucci M. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001, 86:800-3.
2. Kyrle PA, Mannhalter C, Béguin S, Stümpflen A, Hirschl M, Weltermann A, Stain M, Brenner B, Speiser W, Pabinger I, Lechner K, Eichinger S. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol 1998, 18:1287-91.
3. Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, Mannucci PM. Prothrombin A19911G polymorphism and the risk of venous thromboembolism. J Thromb Haemost 2006, 4:2582-6.
4. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-703.
5. Castoldi E, Simioni P, Tormene D, Thomassen MC, Spiezia L, Gavasso S, Rosing J. Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. J Thromb Haemost 2007, 5:971-9.
6. Mazoyer E, Gueguen R, Tiret L, Paulin D, Ripoll L, Bal dit Sollier C, Drouet L. Differential geographic distribution of Factor V Leiden and Factor II Leiden in a French native population (the FITENAT study). J Thromb Haemost 2003, 1. (Suppl. 1): P0359
7. Roussi J, Mazoyer E, Gueguen R, Guillin MC, dit Bal C, Sollier C, Demoulin ML, Bru S, Trocherie C, Drouet L. Age influence on D-Dimer in a large normal French population: the FITENAT study. J Thromb Haemost 2003, 1. (Suppl. 1): P1413
8. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Béguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoaguability. Pathophysiol Haemost Thromb 2002, 32:249-53.
9. Hemker HC, Al Dieri R, Beguin S. Thrombin generation assays: accruing clinical relevance. Curr Opin Hematol 2004, 11:170-5.
10. Hemker HC, Al Dieri R, De Smedt E, Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006, 96:553-61.
11. van Hylckama Vlieg A, Christiansen SC, Luddngton R, Cannegieter SC, Rosendaal FR, Baglin TP. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. Br J Haematol 2007, 138:769-74.
12. Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009, 113:5314-22.
13. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006, 296:397-402.
14. Tripodi A, Legnani C, Chantarangkul V, Cosmi B, Palareti G, Mannucci PM. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost 2008, 6:1327-33.
15. Besser M, Baglin C, Luddington R, van Hylckama Vlieg A, Baglin T. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost 2008, 6:1720-5.
16. Curvers J, Christella M, Thomassen LG, de Ronde H, Bertina RM, Rosendaal FR, Tans G, Rosing J. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 2002, 88:5-11.
17. Tripodi A, Martinelli I, Chantarangkul V, Battaglioli T, Clerici M, Mannucci PM. The endogenous thrombin potential and the risk of venous thromboembolism. Thromb Res 2007, 121:353-9.
18. Duchemin J, Pan-Petesch B, Arnaud B, Blouch MT, Abgrall JF. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 2008, 99:767-73.
19. van Hylckama Vlieg A, Rosendaal FR. High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly. J Thromb Haemost 2003, 1:2677-8.
20. Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. Br Med J 2001, 323:131-4.
21. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002, 22:201-10.
22. Rotteveel RC, Roozendaal KJ, Eijsman L, Hemker HC. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential). Thromb Haemost 1993, 70:959-62.
23. Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD, Folsom AR. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007, 5:1455-61.
24. Wu O, Bayoumi N, Vickers MA, Clark P. ABO (H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008, 6:62-9.
25. Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica 2008, 93:729-34.
26. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985, 37:89-101.
27. Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, Lewis GP, Worcester J. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969, 1:539-42.
28. Schleef M, Strobel E, Dick A, Frank J, Schramm W, Spannagl M. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Br J Haematol 2005, 128:100-7.
29. Dielis AWJH, Castoldi E, Spronk HMH, Van Oerle R, Hamulyak K, Ten Cate H, Rosing J. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2007, 6:125-31.